BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6805423)

  • 1. Activities of tobramycin and azlocillin alone and in combination against experimental osteomyelitis caused by Pseudomonas aeruginosa.
    Norden CW; Shaffer MA
    Antimicrob Agents Chemother; 1982 Jan; 21(1):62-5. PubMed ID: 6805423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.
    Møller NE; Eriksen KR; Feddersen C; Flensborg EW; Høiby N; Norn S; Rosendal K; Schiøtz PO; Skov PS
    Eur J Respir Dis; 1982 Mar; 63(2):130-9. PubMed ID: 6461561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ciprofloxacin with azlocillin plus tobramycin in the therapy of experimental Pseudomonas aeruginosa endocarditis.
    Strunk RW; Gratz JC; Maserati R; Scheld WM
    Antimicrob Agents Chemother; 1985 Sep; 28(3):428-32. PubMed ID: 2934021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of ciprofloxacin, azlocillin, and tobramycin alone and in combination in experimental Pseudomonas sepsis.
    Johnson M; Miniter P; Andriole VT
    J Infect Dis; 1987 Apr; 155(4):783-8. PubMed ID: 3102631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of ciprofloxacin alone and in combination with azlocillin in experimental endocarditis due to Pseudomonas aeruginosa.
    Thauvin C; Lecomte F; Le Boete I; Grise G; Lemeland JF
    Infection; 1989; 17(1):31-4. PubMed ID: 2493429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.
    Rusnak MG; Drake TA; Hackbarth CJ; Sande MA
    J Infect Dis; 1984 Jun; 149(6):980-5. PubMed ID: 6429255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Møller NE; Høiby N
    Scand J Infect Dis Suppl; 1981; 29():87-91. PubMed ID: 6458884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacies of piperacillin, azlocillin, ticarcillin, aztreonam, and tobramycin against experimental Pseudomonas aeruginosa pneumonia.
    Schiff JB; Pennington JE
    Antimicrob Agents Chemother; 1984 Jan; 25(1):49-52. PubMed ID: 6538397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin as therapy for experimental osteomyelitis caused by Pseudomonas aeruginosa.
    Norden CW; Shinners E
    J Infect Dis; 1985 Feb; 151(2):291-4. PubMed ID: 3155780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ability of azlocillin and tobramycin in combination to delay or prevent resistance development in Pseudomonas aeruginosa.
    Wu YL; Scott EM; Po AL; Tariq VN
    J Antimicrob Chemother; 1999 Sep; 44(3):389-92. PubMed ID: 10511408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
    Petit JC; Richard G; Burghoffer B; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a beta-lactam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis.
    Smith AL; Doershuk C; Goldmann D; Gore E; Hilman B; Marks M; Moss R; Ramsey B; Redding G; Rubio T; Williams-Warren J; Wilmott R; Wilson HD; Yogev R
    J Pediatr; 1999 Apr; 134(4):413-21. PubMed ID: 10190914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pseudomonas aeruginosa meningitis treated with azlocillin. 5 cases].
    Vilde JL; Vachon F; Humbert G; Bure A; Bricaire F
    Presse Med; 1984 Mar; 13(13):822-4. PubMed ID: 6231604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azlocillin in cystic fibrosis.
    Malmborg AS; Alfredsson H; Strandvik B
    Isr J Med Sci; 1983 Nov; 19(11):1001-3. PubMed ID: 6662681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fosfomycin, piperacillin, azlocillin. Correlation between therapeutic response of mice infected with Pseudomonas aeruginosa and in vitro data.
    Haag R
    Chemotherapy; 1984; 30(4):227-36. PubMed ID: 6430654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental Pseudomonas aeruginosa sepsis: absence of synergy between ticarcillin and tobramycin.
    Chusid MJ; Davis SD; Sarff LD
    J Lab Clin Med; 1983 Mar; 101(3):441-9. PubMed ID: 6402553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative activities of N-formimidoyl thienamycin, ticarcillin, and tobramycin against experimental Pseudomonas aeruginosa pneumonia.
    Pennington JE; Johnson CE
    Antimicrob Agents Chemother; 1982 Sep; 22(3):406-8. PubMed ID: 6814354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergy of azlocillin with aminoglycosides.
    Chin NX; Neu HC
    J Antimicrob Chemother; 1983 May; 11 Suppl B():33-8. PubMed ID: 6413482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azlocillin in the treatment of serious infection with Pseudomonas aeruginosa.
    Eykyn SJ
    J Antimicrob Chemother; 1982 May; 9(5):395-403. PubMed ID: 6807951
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro comparison of cefpirome and four other beta-lactam antibiotics alone and in combination with tobramycin against clinical isolates of Pseudomonas aeruginosa.
    Cabezudo I; Pfaller M; Bale M; Wenzel R
    Diagn Microbiol Infect Dis; 1989; 12(4):337-41. PubMed ID: 2512048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.